Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

ACCELerated Inhibition of Platelet Aggregation, Inflammation and Ischemia-reperfusion Injury by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01354808
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:37.281239+00:00
Published At
2013-09-24T00:00:00+00:00
Record Updated At
2013-09-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Platelet Aggregation Inhibitors", "Anti-inflammatory Agent", "Myocardial Reperfusion Injury"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-09-24"
protocolSection.identificationModule.nctId
"NCT01354808"
protocolSection.identificationModule.officialTitle
"ACCELerated Inhibition of Platelet Aggregation, Inflammation and Ischemia-reperfusion Injury by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Platelet Aggregation Inhibitors (protocolSection.conditionsModule.conditions)
  • Anti-inflammatory Agent (protocolSection.conditionsModule.conditions)
  • Myocardial Reperfusion Injury (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.